Replies to post #178 on Skystar Bio-pharmaceutical Co. (fka SKBI)

[surf1944]

Skystar to File Audited Financial Results for Full Fiscal Year 2011 on Friday, March 30, 2012

Conference Call to follow on Monday, April 2, 2012 at 7:45 AM (EDT)
MarketwirePress Release: Skystar Bio-Pharmaceutical – 2 hours 1 minute ago

XI'AN, CHINA--(Marketwire -03/29/12)- Skystar Bio-Pharmaceutical Company (NASDAQ: SKBI - News) ("Skystar" or the "Company"), a China-based manufacturer and distributor of veterinary medicines, vaccines, micro-organisms and feed additives, will file its audited financial results for the full fiscal year 2011 on Friday, March 30, 2012 at the end of the business day.

Conference Call Information
The Company will host a conference call on Monday, April 2, 2012 to discuss its financial results for the year ended December 31, 2011. Skystar's conference call will begin promptly at 7:45 a.m. EDT to review fiscal year 2011 financial and operational performance. Mr. Weibing Lu, Skystar's chairman and chief executive officer, will host the call, which will be webcast live.

Webcast
The webcast will be made available on the investor relations section of the Skystar corporate website at http://www.skystarbio-pharmaceutical.com or http://www.investorcalendar.com/IC/CEPage.asp?ID=167900.

Phone dial-in
Telephone access to the conference call will be available in North America by dialing [phone] or internationally by dialing [phone].

An audio replay of the conference call will be available approximately two hours following the conclusion of the call and for the following 30 day period. To access the replay in North America, dial [phone] or, when calling internationally, dial [phone], using replay account code # 286 and conference ID # 391620. An archived replay of the conference webcast will also be available on investor relations section of the Skystar corporate website at http://www.skystarbio-pharmaceutical.com.

To be added to the Company's email distribution for future news releases, please send your request to [e-mail].

About Skystar Bio-Pharmaceutical Company
Skystar is a China-based developer and distributor of veterinary healthcare and medical care products. Skystar has four product lines (veterinary medicines, micro-organisms, vaccines and feed additives) and over 284 products. Skystar has formed strategic sales distribution networks covering 29 provinces throughout China. For additional information, please visit http://www.skystarbio-pharmaceutical.com.